VOL. 31 NO. 6SEPTEMBER-OCTOBER 1997

Features

Giving Thalidomide a Second Chance
The source of tragedy in the middle of this century, thalidomide may now be the source of hope for people with AIDS, cancer, and other illnesses.

Medications and Older Adults
As people age, their medicine cabinets may begin to overflow. To avoid dangerous side effects and interactions, communication and organization are essential.

Why Should FDA Regulate Drugs?
That's a question many people raise as FDA strives to maintain a delicate balance between too much regulation and not enough. The answer is explained in an interview with the director of FDA's drug center.

Schizophrenia: Real Lives, Imaginary Terror
Reality and imagination become one for people suffering with schizophrenia. Getting back to reality relies on potent medication and various forms of "talk" therapy.

Teen Scene: Bone Builders
Strong bones that will support you now and throughout your life are easy to get with exercise and foods rich in calcium.

Departments

Updates

The latest information on FDA-related issues, gathered from FDA Press Releases, Talk Papers, and other sources.

Notebook

A potpourri of items of interest gathered from the Federal Register and other sources.

Investigators' Reports

Selected cases illustrating regulatory and administrative actions--such as inspections, recalls, seizures, and court proceedings--by FDA's regional and district offices across the country

Summaries of Court Actions will not appear in this issue of FDA Consumer, but will return in the November-December issue.